Author Question: A hypereutectic piston has a higher ________. A) Silicon content B) Nickel content C) Weight ... (Read 90 times)

james

  • Hero Member
  • *****
  • Posts: 573
A hypereutectic piston has a higher ________.
 
  A) Silicon content B) Nickel content
  C) Weight than an aluminum piston D) Tin content

Question 2

Two bulbs are connected in parallel to a 12-volt battery. One bulb has a resistance of 6 ohms and the other bulb has a resistance of 2 ohms. Technician A says that only the 2-ohm bulb will light because all of the current will flow through the path with the least resistance and no current will flow through the 6-ohm bulb. Technician B says that the 6-ohm bulb will be dimmer than the 2-ohm bulb. Which technician is correct?
 
  A) Technician A only B) Technician B only
  C) Both technicians A and B D) Neither technician A nor B



billybob123

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

A

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library